Thioaptamer Diagnostic System (TDS) by Yang, Xianbin
5Thioaptamer Diagnostic  
System (TDS)   
Quickly identiﬁes up to 32 biomarkers in a single sample
AM Biotechnologies, LLC, in partnership with Sandia National Laboratories, 
has developed a diagnostic device that quickly detects sampled biomarkers.  
The TDS quickly quantiﬁes clinically relevant biomarkers using only microliters 
of a single sample. The system combines ambient-stable, long shelf-life aﬃnity 
assays with handheld, microﬂuidic gel electrophoresis aﬃnity assay quantiﬁca-
tion technology. The TDS is easy to use, operates in microgravity, and permits 
simultaneous quantiﬁcation of 32 biomarkers.
In Phase I of the project, the partners demonstrated that a thioaptamer assay 
used in the microﬂuidic instrument could quantify a speciﬁc biomarker in 
serum in the low nanomolar range. The team also identiﬁed novel aﬃnity 
agents to bone-speciﬁc alkaline phosphatase (BAP) and demonstrated their 
ability to detect BAP with the microﬂuidic instrument. In Phase II, AM Biotech 
expanded the number of ambient aﬃnity agents and demonstrated a TDS  
prototype. In the long term, the clinical version of the TDS will provide a 
robust, ﬂight-tested diagnostic capability for space exploration missions.
Applications
NASA 
 ` In-ﬂight diagnostics for health 
research and monitoring
 ` Opportunities for novel bio-
marker discovery
 ` Research on the International 
Space Station (ISS) regard-
ing human adaptation to 
microgravity
Commercial
 ` Clinical research tool for novel 
biomarker discovery
 ` Handheld diagnostic system for 
remote, resource-poor locations
 ` Rapid diagnostic device for use 
by ﬁrst responders and physician 
oﬃces
 ` Aﬀordable diagnostic system for 
university research laboratories 
and companies with limited 
budgets
Phase II Objectives
 ` Optimize binding agents  
demonstrated in Phase I of the 
project
 ` Select additional binding agents for 
next round of biomarkers
 ` Improve assay performance in 
serum
 ` Develop stand-alone prototype for 
NASA demonstrations
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 ` Eliminates the need to freeze 
samples on the ISS and return them 
to Earth for ground-based testing
 ` Operates in microgravity
 ` Is easy to use, self-contained, 
automated, and lightweight  
(<10 pounds)
 ` Requires minimal sample volumes 
(microliters)
 ` Is sensitive and rapid (<10 minutes) 
 ` Permits simultaneous quantitation 
of 8–32 biomarkers
 ` Offers long-term reagent stability at 
ambient temperatures
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